Merabishvili Maia, Pirnay Jean-Paul, De Vos Daniel
Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Bruynstraat 1, Brussels, 1120, Belgium.
Methods Mol Biol. 2018;1693:99-110. doi: 10.1007/978-1-4939-7395-8_9.
Correctly designed bacteriophage therapeutics are the cornerstone for a successful outcome of bacteriophage therapy. Here we overview strategies on how to choose bacteriophages and their bacterial hosts at different steps of a bacteriophage cocktail development in order to comply with all quality and safety requirements based on the already existing essentially empirical experience in bacteriophage therapy and current accomplishments in modern biomedical sciences. A modification of the classic Appelmans' method (1922) to assess stability of bacteriophage activity in liquid media is presented in order to improve the overall performance of therapeutic bacteriophages individually and collectively in the cocktail.
设计合理的噬菌体疗法是噬菌体治疗取得成功的基石。在此,我们概述了在噬菌体鸡尾酒疗法开发的不同阶段如何选择噬菌体及其细菌宿主的策略,以便基于噬菌体治疗中已有的基本经验以及现代生物医学科学的当前成果,符合所有质量和安全要求。为了提高治疗性噬菌体在鸡尾酒疗法中单独和集体的整体性能,我们提出了对经典的阿佩尔曼斯方法(1922年)的改进,以评估噬菌体在液体培养基中的活性稳定性。